Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Intangibles (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Intangibles over the past 15 years, most recently at $4.2 million for Q2 2025.

  • For Q2 2025, Intangibles changed 0.0% year-over-year to $4.2 million; the TTM value through May 2025 reached $4.2 million, changed 0.0%, while the annual FY2025 figure was $4.2 million, 0.0% changed from the prior year.
  • Intangibles for Q2 2025 was $4.2 million at Lifecore Biomedical, Inc. \De\, roughly flat from $4.2 million in the prior quarter.
  • Over five years, Intangibles peaked at $4.2 million in Q1 2021 and troughed at $4.2 million in Q1 2021.
  • A 5-year average of $4.2 million and a median of $4.2 million in 2021 define the central range for Intangibles.
  • On a YoY basis, Intangibles climbed as much as 0.0% in 2021 and fell as far as 83.42% in 2021.
  • Year by year, Intangibles stood at $4.2 million in 2021, then changed by 0.0% to $4.2 million in 2022, then changed by 0.0% to $4.2 million in 2023, then changed by 0.0% to $4.2 million in 2024, then changed by 0.0% to $4.2 million in 2025.
  • Business Quant data shows Intangibles for LFCR at $4.2 million in Q2 2025, $4.2 million in Q1 2025, and $4.2 million in Q4 2024.